TechTransfer Day
Smart Contact Lenses: Embedded Technologies beyond Vision
SAARBRÜCKEN GERMANY
September 29 & 30, 2025

Speakers and Discussion Moderators
See the Future.
Shape the Future.
Smart contact lenses are set to redefine how we see, sense, and connect with the world. From augmented reality navigation to disease monitoring and therapy, next-generation lenses promise powerful new functions—all in an invisible, wearable form. But moving from prototype to product requires more than innovation: it demands seamless integration, user comfort, and sustainable design.
Join industry leaders, researchers, and innovators as we explore the latest advances in materials science, device engineering, and system design. Engage in focused seminars and dynamic discussion tables to exchange insights, forge partnerships, and accelerate progress from lab to market.
Don’t miss this unique opportunity to connect, collaborate, and lead the next wave of smart contact lens innovation. Register now and be part of what’s next.
Register
Program
September 29
Registration, welcome lunch
Smart contact lenses for
glaucoma care and beyond
Prof. Chi Hwan Lee, Purdue University (US)
Microfluidic Contact Lenses
for Ocular Diagnostics
Prof. Ali Yetisen, Imperial College London (UK)
Discussion Session 1
From Sci-Fi to Daily Wear: Are Smart Lenses Ready for Prime Time?
Moderator: Enrique Vega (Azalea Vision)
Coffee break
Next-Generation Personalized Healthcare with Smart Contact Lenses
Prof. Jang-Ung Park, Yonsei University (KR)
Towards Precision Ocular Diagnostics: Tear Film Biomarkers and Inflammatory Signatures
Prof. María González-García, University of Valladolid (ESP)
Current major trends in the global contact lens market. What and why.
Prof. Philip Morgan, Eurolens Manchester (UK)
Discussion Session 2
Visionary Diagnostics: Looking the eyes,
seeing the future
Moderator: Sacha Cerboni (Sensimed AG)
Dinner (downtown)
September 30
Seeing the Future:
The Latest in Contact Lens Tech
Prof. Jason J Nichols, University Alabama (US)
Self-lubricating
Contact Lenses
Prof. Aránzazu del Campo, Leibniz INM (DE)
Discussion Session 3
Drug-Eluting Contact Lenses: Opportunities and Challenges
Moderator: Max Ostermeier (Implandata GmbH)
Farewell lunch
Speaker info
Prof. Chi Hwan Lee
Chi Hwan Lee is a Professor of Biomedical Engineering and Mechanical Engineering at Purdue University, West Lafayette, Indianapolis. His Research Group focuses on bridging a critical gap between engineering and unmet clinical needs. It explores a variety of wearable biomedical devices that can be safely attached to the skin or eye, enabling continuous remote assessment of human health and diseases


Prof. Ali Yetisen
Ali K. Yetisen is an Associate Professor and Senior Lecturer in the Department of Chemical Engineering at Imperial College London. The Centre for Biochemical Sensors develops biochemical sensors, optical materials, and devices for medical diagnostics, therapeutics, and imaging.
Prof. María González-García
María González-García is a Professor of Optometry at the University of Valladolid and a researcher at the Institute of Applied Ophthalmobiology (IOBA). Her work focuses on the interaction between contact lenses and the ocular surface, with a particular interest in contact lens tolerance. Her research explores the identification of tear film biomarkers that may aid in the diagnosis and management of dry eye disease and contact lens discomfort.


Prof. Philip Morgan
Philip Morgan is Professor of Optometry and Director of Eurolens Research at The University of Manchester. He is President of the International Association of Contact Lens Educators and is Past President of the International Society for Contact Lens Research. His main research interests relate to the clinical performance of contact lenses. He has managed an annual international survey of contact lens prescribing trends since 1996.
Prof. Jason J. Nichols
Jason J. Nichols is Professor at the School of Optometry and Senior Associate Vice President for Research at the University of Alabama (US). He is an expert in ocular surface and his main research interests are in dry eye, meibomian gland disease, and pharmaceutical and medical device development and testing. He is currently Editor of Contact Lens Spectrum and Contact Lenses Today® and has Chaired the AAO’s Research Committee and the Tear Film and Ocular Surface (TFOS) Society’s Medical and Scientific Advisory Board.


Prof. Jang-Ung Park
Jang-Ung Park is Prof. for Materials Science and Engineering at Yonsei University in South Korea. His research focuses on wearable opto-electronic devices as free-form electronics with IoT (Internet of Things) technology, including transparent, foldable, stretchable, 4D-printable, or self-healable properties. The group combines electronics with human life and environment, and spans fundamental science and technology transfer.
Prof. Aránzazu del Campo
Aránzazu del Campo is the Scientific Director and CEO of the INM– Leibniz Institute for New Materials and Professor for Materials Chemistry at Saarland University. Her research focuses on hydrogel materials for cell encapsulation and biofabrication of therapeutic devices. In the field of ocular drug delivery, her group works on self-replenishable, drug eluting contact lenses for zero-waste therapeutic solutions.

Discussion Moderators
Sacha Cerboni
Sacha Cerboni is Founder and Chief Quality Officer of Sensimed (Switzerland). He is an expert in regulatory and quality assurance with more than 10 years’ experience in the medical device start-up environment. He has extensive experience with health care-related data analysis and the introduction of novel health management programs.


Max G. Ostermeier
Max G. Ostermeier is Co-Founder and General Manager of Implandata Ophthalmic Products GmbH (Germany). He drives innovation in ophthalmic surgical products by supporting commercial development of technologically advanced products in cooperation with research institutions, by building operational capabilities for aggressively growing companies, and by creating business and attracting potential acquirers in the global market.
Enrique Vega
Enrique Vega is Co-Founder and CEO of Azalea Vision (Belgium), which develops solutions for ophthalmic diseases. He has over 25 years of international management experience in start-ups and global companies. Enrique has a strong background in medical device development for ophthalmology, neuromodulation, sleep apnea, cardiology, and vascular intervention.
